1. Home
  2. BEAT vs FORA Comparison

BEAT vs FORA Comparison

Compare BEAT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • FORA
  • Stock Information
  • Founded
  • BEAT 2015
  • FORA 2014
  • Country
  • BEAT United States
  • FORA United States
  • Employees
  • BEAT N/A
  • FORA N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • FORA Computer Software: Prepackaged Software
  • Sector
  • BEAT Technology
  • FORA Technology
  • Exchange
  • BEAT Nasdaq
  • FORA Nasdaq
  • Market Cap
  • BEAT 58.0M
  • FORA 69.4M
  • IPO Year
  • BEAT 2021
  • FORA N/A
  • Fundamental
  • Price
  • BEAT $1.79
  • FORA $2.28
  • Analyst Decision
  • BEAT Buy
  • FORA Strong Buy
  • Analyst Count
  • BEAT 1
  • FORA 1
  • Target Price
  • BEAT $8.00
  • FORA $5.00
  • AVG Volume (30 Days)
  • BEAT 99.2K
  • FORA 21.9K
  • Earning Date
  • BEAT 11-06-2025
  • FORA 11-12-2025
  • Dividend Yield
  • BEAT N/A
  • FORA N/A
  • EPS Growth
  • BEAT N/A
  • FORA N/A
  • EPS
  • BEAT N/A
  • FORA N/A
  • Revenue
  • BEAT N/A
  • FORA $25,031,040.00
  • Revenue This Year
  • BEAT N/A
  • FORA $47.82
  • Revenue Next Year
  • BEAT $19.35
  • FORA $10.11
  • P/E Ratio
  • BEAT N/A
  • FORA N/A
  • Revenue Growth
  • BEAT N/A
  • FORA 18.59
  • 52 Week Low
  • BEAT $0.91
  • FORA $1.64
  • 52 Week High
  • BEAT $3.48
  • FORA $4.03
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 60.65
  • FORA 54.91
  • Support Level
  • BEAT $1.74
  • FORA $2.20
  • Resistance Level
  • BEAT $2.03
  • FORA $2.33
  • Average True Range (ATR)
  • BEAT 0.11
  • FORA 0.07
  • MACD
  • BEAT 0.00
  • FORA -0.01
  • Stochastic Oscillator
  • BEAT 40.00
  • FORA 27.03

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: